Hepatitis C Stocks

Description:

This portfolio consists of public companies that are researching a cure for Hepatitis C which affects 170 million people worldwide

"The hottest area in drug development right now and for the next couple of years is hepatitis C," said Kris Jenner, whow runs the $1.7 billion T. Rowe Price Health Sciences Fund.
Portfolio not tracked.

Most Viewed Portfolios

View All

Articles

5 Earnings Short-Squeeze Plays

11.20.14 | 09:26 PM

DELAFIELD, Wis. (Stockpickr) -- Short-sellers hate being caught short a stock that reports a blowout quarter. When this happens, we often see a tra...

5 Must-See Charts

11.20.14 | 10:59 AM

BALTIMORE (Stockpickr) -- We've had a pretty innocuous week so far in the markets, the big indices adding a few dozen basis points between Monday's...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter